Abstract
ObjectiveThe objective of this study was to evaluate the comparative cost-effectiveness of lenvatinib (LEN) plus transarterial chemoembolisation (TACE) (LEN-TACE) and LEN alone to treat advanced hepatocellular carcinoma (HCC) from the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have